• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: March 23-27, 2009

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Frank Torti, Acting Commissioner3/24/2009Washington, DCN/AEdward Porter, (Research!America), Diane Baker, (Genetic Alliance), Dr. Francis Collins, (National Human Genome Research Institute, NIH), Elizabeth Baker Keffer, (Research! America Board), Larry McEnerney and Cathe McEnerney, (Univ of Chicago), Amy Porter, (Foundation for the NIH), Becky Rogers, (Research!America Board), Pat Terry, (PXE International), Sharon Terry, (Genetic Alliance), Susan Whitehead, (The Whitehead Charitable Foundation)Attended the 2009 Research!America Advocacy Awards and Tribute Reception
John Dyer, Deputy Commissioner for Operations and Chief Operating Officer3/23/09 through 3/27/09N/AN/AN/ANo significant meetings
Murray Lumpkin, Deputy Commissioner for International and Special Programs3/23-25/09Berlin, GermanyN/AN/ADrug Information Association Euromeeting
Randall Lutter, Deputy Commissioner for Policy3/23/09 through 3/27/09N/AN/AN/ANo significant meetings
Janet Woodcock, Director, Center for Drug Evaluation and Research3/24/09Washington, DCRobert Becker, Francis KalushJean Grem ( University of Nebraska Med. Center) Steve Averbuch ( Bristol-Meyers Squibb)FDA-Industry IVD/Companion Diagnostic Drug Roundtable
Janet Woodcock, Director, Center for Drug Evaluation and Research3/26/09Washington, DCN/AKaren Smith (Astra Zeneca) Nancy Nielsen ( American Medical  Association)Institute Of Medicine Roundtable on Evidence Based Medcine
Michael Chappell, Acting Associate Commissioner, Office of Regulatory Affairs3/23/09 through 3/27/09N/AN/AN/ANo significant meetings
Jesse Goodman, Acting Chief Medical Officer3/23/09 through 3/27/09N/AN/AN/ANo significant meetings
Karen Midthun, Acting Director, Center for Biologics Evaluation and Research3/23-24/09Bethesda, MDN/AN/AOpening remarks, Public workshop on alpha-1 antitrypsin augmentation therapy
Daniel Schultz, Director, Center for Devices and Radiological Health3/23/09 through 3/27/09N/AN/AN/ANo significant meetings
Stephen Sundlof, Center for Food Safety and Applied Nutrition3/23/09 through 3/27/09N/AN/AN/ANo significant meetings
Bernadette Dunham, Director, Center for Veterinary Medicine3/23/2009Rockville, MDBurt Pritchett, Shannon Jordre, Dan McChesney, William Flynn, Dave White, Steve Vaughn, Sema Hashemi, Merton SmithMr. Watanabe, Mr. Kojima (Embassy of Japan)Courtesy Visit
Bernadette Dunham, Director, Center for Veterinary Medicine3/27/09Rockville, MDWilliam Flynn, Dave White, Steve Vaughn, Tracey Forfa, Merton Smith, Dan McChesneyDr. Marne Platt, Dr. Tony Benitz, S. Lee Whaley (Novartis Animal Health)General Discussion
Bernadette Dunham, Director, Center for Veterinary Medicine3/27/09Rockville, MDWilliam Flynn, Tracey Forfa, Dan McChesney, Steve Vaughn, Dave WhiteDrs, Andrew Maccabe, Patricia Griffin, Fred AnguloGeneral Discussion
William Slikker, Director, National Center for Toxicological Research3/23-25/09Berlin, GermanyN/AIndustry, academia and regulatory professionals from over 50 countriesDrug Information Association's 21st Annual EuroMeeting Berlin 2009
Jeffrey M. Senger, Acting Chief Counsel3/23/09 through 3/27/09N/AN/AN/ANo significant meetings